Introduction of a Specific Dermatological Rehabilitation Programme for Patients with Chronic Pruritus: A Pilot Study
DOI:
https://doi.org/10.2340/actadv.v102.2930Keywords:
itch, chronic pruritus, rehabilitation, patient-reported outcome, guideline, clinical trials, clinical researchAbstract
Chronic pruritus is a common symptom, associated with several severe medical conditions, great psychological burden, and reduced quality of life. It also poses socio-economic challenges concerning patients’ work loss and healthcare costs. In Germany, medical rehabilitation programmes represent an integral part of the medical care of patients with chronic inflammatory skin diseases. However, such programmes play only a rudimentary role in the treatment of other dermatological diseases, such as dermatological oncology, genetic skin diseases, and chronic pruritus. Therefore, a specific antipruritic dermatological rehabilitation programme was developed in cooperation between the Department of Dermatology of the Medical Rehabilitation Center Bad Bentheim and the Center for Chronic Pruritus of the University Hospital of Muenster, Germany. This prospective study compared short-term patient-reported outcomes (n = 121) at the beginning and end of the rehabilitation programme. The majority of subjects had chronic pruritus on primary diseased, inflamed skin. Significant improvements in pruritus intensity (p ≤ 0.001), quality of life (p ≤ 0.001), anxiety symptoms (p ≤ 0.001) and depression (p ≤ 0.001), as well as an overall patient-relevant benefit (Patient Benefit Index 2.6 ± 1.06) and treatment-related patients’ satisfaction, were shown. This suggests that implementation of this standardized rehabilitation programme for treatment of patients with chronic pruritus was successful.
Downloads
References
Ständer S, Weisshaar E, Mettang T, Szepietowski JC, Carstens E, Ikoma A, et al. Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol 2007; 87: 291-294.
https://doi.org/10.2340/00015555-0305 DOI: https://doi.org/10.2340/00015555-0305
Ständer S, Schäfer I, Phan NQ, Blome C, Herberger K, Heigel H, et al. Prevalence of chronic pruritus in Germany: results of a cross-sectional study in a sample working population of 11,730. Dermatology 2010; 221: 229-235.
https://doi.org/10.1159/000319862 DOI: https://doi.org/10.1159/000319862
Matterne U, Apfelbacher CJ, Loerbroks A, Schwarzer T, Büttner M, Ofenloch R, et al. Prevalence, correlates and characteristics of chronic pruritus: a population-based cross-sectional study. Acta Derm Venereol 2011; 91: 674-679.
https://doi.org/10.2340/00015555-1159 DOI: https://doi.org/10.2340/00015555-1159
Matterne U, Apfelbacher CJ, Vogelgsang L, Loerbroks A, Weisshaar E. Incidence and determinants of chronic pruritus: a population-based cohort study. Acta Derm Venereol 2013; 93: 532-537.
https://doi.org/10.2340/00015555-1572 DOI: https://doi.org/10.2340/00015555-1572
Ständer S, Zeidler C, Augustin M, Bayer G, Kremer AE, Legat FJ, et al. S2k Guidelines for the diagnosis and treatment of chronic pruritus - update - short version. J Dtsch Dermatol Ges 2017; 15: 860-872.
https://doi.org/10.1111/ddg.13304 DOI: https://doi.org/10.1111/ddg.13304
Grundmann SA, Stratmann E, Brehler R, Luger TA, Ständer S. Lactase deficiency: a potential novel aetiological factor in chronic pruritus of unknown origin. Acta Derm Venereol 2011; 91: 698-703.
https://doi.org/10.2340/00015555-1150 DOI: https://doi.org/10.2340/00015555-1150
Ständer S, Blome C, Breil B, Bruland P, Darsow U, Dugas M, et al. [Erfassung von Pruritus - aktuelle Standards und Implikationen für die Praxis - Konsensuspaper der Initiative Pruritusparameter der Arbeitsgemeinschaft Pruritusforschung (AGP). Hautarzt 2012; 63: 521-522, 524-531.
https://doi.org/10.1007/s00105-011-2318-3 DOI: https://doi.org/10.1007/s00105-011-2318-3
Kini SP, DeLong LK, Veledar E, McKenzie-Brown AM, Schaufele M, Chen SC. The impact of pruritus on quality of life: the skin equivalent of pain. Arch Dermatol 2011; 147: 1153-1156.
https://doi.org/10.1001/archdermatol.2011.178 DOI: https://doi.org/10.1001/archdermatol.2011.178
Weisshaar E, Apfelbacher C, Jäger G, Zimmermann E, Bruckner T, Diepgen TL, et al. Pruritus as a leading symptom: clinical characteristics and quality of life in German and Ugandan patients. Br J Dermatol 2006; 155: 957-964.
https://doi.org/10.1111/j.1365-2133.2006.07430.x DOI: https://doi.org/10.1111/j.1365-2133.2006.07430.x
Lavery MJ, Stull C, Kinney MO, Yosipovitch G. Nocturnal pruritus: the battle for a peaceful night's sleep. Int J Mol Sci 2016; 17: 425.
https://doi.org/10.3390/ijms17030425 DOI: https://doi.org/10.3390/ijms17030425
Schneider G, Driesch G, Heuft G, Evers S, Luger TA, Ständer S. Psychosomatic cofactors and psychiatric comorbidity in patients with chronic itch. Clin Exp Dermatol 2006; 31: 762-767.
https://doi.org/10.1111/j.1365-2230.2006.02211.x DOI: https://doi.org/10.1111/j.1365-2230.2006.02211.x
Sheehan-Dare RA, Henderson MJ, Cotterill JA. Anxiety and depression in patients with chronic urticaria and generalized pruritus. Br J Dermatol 1990; 123: 769-774.
https://doi.org/10.1111/j.1365-2133.1990.tb04195.x DOI: https://doi.org/10.1111/j.1365-2133.1990.tb04195.x
Ferm I, Sterner M, Wallengren J. Somatic and psychiatric comorbidity in patients with chronic pruritus. Acta Derm Venereol 2010; 90: 395-400.
https://doi.org/10.2340/00015555-0864 DOI: https://doi.org/10.2340/00015555-0864
Mazeh D, Melamed Y, Cholostoy A, Aharonovitzch V, Weizman A, Yosipovitch G. Itching in the psychiatric ward. Acta Derm Venereol 2008; 88: 128-131.
https://doi.org/10.2340/00015555-0406 DOI: https://doi.org/10.2340/00015555-0406
Dalgard F, Lien L, Dalen I. Itch in the community: associations with psychosocial factors among adults. J Eur Acad Dermatol Venereol 2007; 21: 1215-1219.
https://doi.org/10.1111/j.1468-3083.2007.02234.x DOI: https://doi.org/10.1111/j.1468-3083.2007.02234.x
Halvorsen JA, Dalgard F, Thoresen M, Thoresen M, Bjertness E, Lien L. Itch and mental distress: a cross-sectional study among late adolescents. Acta Derm Venereol 2009; 89: 39-44.
https://doi.org/10.2340/00015555-0554 DOI: https://doi.org/10.2340/00015555-0554
Weisshaar E, Szepietowski JC, Dalgard FJ, Garcovich S, Gieler U, Giménez-Arnau AM, et al. European S2k Guideline on Chronic Pruritus. Acta Derm Venereol 2019; 99: 469-506.
https://doi.org/10.2340/00015555-3164 DOI: https://doi.org/10.2340/00015555-3164
Weisshaar E, Ständer S, Gieler U, Matterne U, Darsow U. Entwicklung eines deutschsprachigen Fragebogens zur Erfassung von chronischem Pruritus (AGP-Fragebogen) Hautarzt 2011; 62: 914-927.
https://doi.org/10.1007/s00105-011-2236-4 DOI: https://doi.org/10.1007/s00105-011-2236-4
Reich A, Riepe C, Anastasiadou Z, Mędrek K, Augustin M, Szepietowski JC, et al. Itch assessment with visual analogue scale and numerical rating scale: determination of minimal clinically important difference in chronic itch. Acta Derm Venereol 2016; 96: 978-980.
https://doi.org/10.2340/00015555-2433 DOI: https://doi.org/10.2340/00015555-2433
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
https://doi.org/10.1111/j.1365-2230.1994.tb01167.x DOI: https://doi.org/10.1111/j.1365-2230.1994.tb01167.x
Zeidler C, Steinke S, Riepe C, Bruland P, Soto-Rey I, Storck M, et al. Cross-European validation of the ItchyQoL in pruritic dermatoses. J Eur Acad Dermatol Venereol 2019; 33: 391-397.
https://doi.org/10.1111/jdv.15225 DOI: https://doi.org/10.1111/jdv.15225
Krause K, Kessler B, Weller K, Veidt J, Chen SC, Martus P, et al. German version of ItchyQoL: validation and initial clinical findings. Acta Derm Venereol 2013; 93: 562-568.
https://doi.org/10.2340/00015555-1544 DOI: https://doi.org/10.2340/00015555-1544
Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006; 166: 1092-1097.
https://doi.org/10.1001/archinte.166.10.1092 DOI: https://doi.org/10.1001/archinte.166.10.1092
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-613.
https://doi.org/10.1046/j.1525-1497.2001.016009606.x DOI: https://doi.org/10.1046/j.1525-1497.2001.016009606.x
Augustin M, Radtke MA, Zschocke I, Blome C, Behechtnejad J, Schafer I, et al. The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases. Arch Dermatol Res 2009; 301: 561-571.
https://doi.org/10.1007/s00403-009-0928-8 DOI: https://doi.org/10.1007/s00403-009-0928-8
Blome C, Augustin M. Evaluation des therapeutischen Nutzens aus Patientensicht: Der Patient Benefit Index (PBI) als Beispiel für zielorientierte Präferenz- und Outcome-Messung. Gesundh ökon Qual manag 2010; 15: 236-240.
https://doi.org/10.1055/s-0029-1245662 DOI: https://doi.org/10.1055/s-0029-1245662
Foundation TR. The R Project for Statistical Computing. The R Foundation. 2021.
Reich A, Heisig M, Phan NQ, Taneda K, Takamori K, Takeuchi S, et al. Visual analogue scale: evaluation of the instrument for the assessment of pruritus. Acta Derm Venereol 2012; 92: 497-501.
https://doi.org/10.2340/00015555-1265 DOI: https://doi.org/10.2340/00015555-1265
Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: what do Dermatology Life Quality Index scores mean? J Invest Dermatol 2005; 125: 659-664.
https://doi.org/10.1111/j.0022-202X.2005.23621.x DOI: https://doi.org/10.1111/j.0022-202X.2005.23621.x
Hattori Y, Hattori K, Suzuki T, Matsuda N. Recent advances in the pathophysiology and molecular basis of sepsis-associated organ dysfunction: novel therapeutic implications and challenges. Pharmacol Ther 2017; 177: 56-66.
https://doi.org/10.1016/j.pharmthera.2017.02.040 DOI: https://doi.org/10.1016/j.pharmthera.2017.02.040
Love EM, Marrazzo GA, Kini S, Veledar E, Chen SC. ItchyQoL bands: pilot clinical interpretation of scores. Acta Derm Venereol 2015; 95: 114-115.
https://doi.org/10.2340/00015555-1891 DOI: https://doi.org/10.2340/00015555-1891
Frese T, Herrmann K, Sandholzer H. Pruritus as reason for encounter in general practice. J Clin Med Res 2011; 3: 223-229.
https://doi.org/10.4021/jocmr632w DOI: https://doi.org/10.4021/jocmr632w
Stinco G, Trevisan G, Piccirillo F, Pezzetta S, Errichetti E, di Meo N, et al. Pruritus in chronic plaque psoriasis: a questionnaire-based study of 230 Italian patients. Acta Dermatovenerol Croat 2014; 22: 122-128.
Ständer S, Yosipovitch G, Legat FJ, Lacour JP, Paul C, Narbutt J, et al. Trial of nemolizumab in moderate-to-severe prurigo nodularis. N Engl J Med 2020; 382: 706-716.
https://doi.org/10.1056/NEJMoa1908316 DOI: https://doi.org/10.1056/NEJMoa1908316
Ständer S, Spellman MC, Kwon P, Yosipovitch G. The NK1 receptor antagonist serlopitant for treatment of chronic pruritus. Expert Opin Investig Drugs 2019; 28: 659-666.
https://doi.org/10.1080/13543784.2019.1638910 DOI: https://doi.org/10.1080/13543784.2019.1638910
He A, Alhariri JM, Sweren RJ, Kwatra MM, Kwatra SG. Aprepitant for the treatment of chronic refractory pruritus. BioMed Res Int 2017; 2017: 4790810.
https://doi.org/10.1155/2017/4790810 DOI: https://doi.org/10.1155/2017/4790810
IQWiG. Nutzenbewertung der Balneophototherapie: Abschlussbericht N04/04: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen; 2006 21.12.2006. Report No.: N04/04.
Mollanazar NK, Koch SD, Yosipovitch G. Epidemiology of chronic pruritus: where have we been and where are we going? Curr Derm Rep 2015; 4: 20-29.
https://doi.org/10.1007/s13671-014-0093-y DOI: https://doi.org/10.1007/s13671-014-0093-y
AWMF online. German S1-Guideline "Stationäre dermatologische Rehabilitation" (extended version). [accessed 2022 Oct 30]. Available from: https://www.awmf.org/uploads/tx_szleitlinien/013-083l_S1_Stationaere-dermatologische-Rehabilitation_2020-04_01.pdf.
Medical Service of the German Association of Health Insurance Companies, Guideline for Assessment of Rehabilitation according to § 282 SGB V: Vorsorge und Rehabilitation. July 2018. [accessed 2022 Oct 3]. Available from: https://www.mds-ev.de/fileadmin/dokumente/Publikationen/GKV/Begutachtungsgrundlagen_GKV/BGAVorsorge-Reha_18-07-02.pdf.
German National Pension Fund. Statistics of the German National Pension Fund, Services for Medical Rehabilitation, Services for retention in professional life: details to services, duration, diagnoses, and professions 2018, Band 216
Berlin August 2019. [accessed 2022 Oct 3]. Available from: https://www.deutsche-rentenversicherung.de/SharedDocs/Downloads/DE/Statistiken-undBerichte/statistikpublikationen/statistikband_rehabilitation_2018.pdf?__blob=publicationFile&v=2.
Müller S, Bieber T, Ständer S. Therapeutic potential of biologics in prurigo nodularis. Expert Opin Biol Ther 2022; 22: 47-58.
https://doi.org/10.1080/14712598.2021.1958777 DOI: https://doi.org/10.1080/14712598.2021.1958777
Weisshaar E, Szepietowski JC, Bernhard JD, Hait H, Legat FJ, Nattkemper L, et al. Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: results of a phase 2 randomized controlled trial with an open-label extension phase. J Eur Acad Dermatol Venereol 2022; 36: 453-461.
https://doi.org/10.1111/jdv.17816 DOI: https://doi.org/10.1111/jdv.17816
Blome C, Augustin M, Siepmann D, Phan NQ, Rustenbach SJ, Ständer S. Measuring patient-relevant benefits in pruritus treatment: development and validation of a specific outcomes tool. Br J Dermatol 2009; 161: 1143-1148.
https://doi.org/10.1111/j.1365-2133.2009.09328.x DOI: https://doi.org/10.1111/j.1365-2133.2009.09328.x
Zeidler C, Pereira M, Dugas M, Augustin M, Storck M, Weyer-Elberich V, et al. The burden in chronic prurigo: patients with chronic prurigo suffer more than patients with chronic pruritus on non-lesional skin. J Eur Acad Dermatol Venereol 2021; 35: 738-743.
https://doi.org/10.1111/jdv.16929 DOI: https://doi.org/10.1111/jdv.16929
Tsianakas A, Mrowietz M. Pruritus bei Psoriasis: Profil und Therapie. Hautarzt 2016; 67: 601-605.
https://doi.org/10.1007/s00105-016-3835-x DOI: https://doi.org/10.1007/s00105-016-3835-x
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Sophia von Martial, Lisa Kok, Sonja Gründel, Matthias Augustin, Christine Blome, Claudia Zeidler, Kerstin Steinbrink, Sonja Ständer, Athanasios Tsianakas
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
